AI Analysis – Experimental
The legislation mandates that unused portions of specific ophthalmic drugs must be offered to patients upon discharge from hospitals or surgical facilities if needed for continued treatment, with compliance required from these facilities.
Introduced in the House
Feb. 12, 2025
Introduced
by
Rep. Samantha Steckloff (D-19)
and 23 co-sponsors
Co-sponsored by Reps.
Julie Rogers (D-41), Donavan McKinney (D-11), Cynthia Neeley (D-70), Carol Glanville (D-84), Carrie Rheingans (D-47), Regina Weiss (D-5), Laurie Pohutsky (D-17), Natalie Price (D-6), Phil Skaggs (D-80), Jason Morgan (D-23), Morgan Foreman (D-33), Sharon MacDonell (D-56), Stephanie Young (D-16), Jimmie Wilson (D-32), Emily Dievendorf (D-77), Julie Brixie (D-73), Erin Byrnes (D-15), Denise Mentzer (D-61), Gina Johnsen (R-78), Mike Hoadley (R-99), Jay DeBoyer (R-63), Kelly Breen (D-21) and Stephen Wooden (D-81)
Referred to the Committee on Health Policy
